University of Saskatchewan
Saskatoon, Saskatchewan, S7N5B2, Canada
NCT Number: NCT04872140
Female endurance athletes are susceptible to iron deficiency and this can impact their exercise performance. This study assesses the impact of an pea protein supplement with high iron bio-availability on iron status and exercise performance.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Not applicable
Saskatoon, Saskatchewan, S7N5B2, Canada
Female endurance athletes are susceptible to iron deficiency due to poor iron intake from diets or possibly because of destruction of red blood cells during foot-strike hemolysis. This study will evaluate the impact of 8-weeks of iron supplementation through consumption of a pea-protein power that has high iron bio-availability due to low phytate levels. This will be compared to consumption of regular iron protein powder and maltodextrin placebo by randomizing participants to three groups. Participants will be assessed at baseline and after 8 weeks of supplementation for exercise performance (maximal aerobic capacity and a 5 km time trial running test), blood levels of ferritin and hemoglobin, and body composition (fat mass and lean tissue mass).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exercise performance with low phytate pea powder
Exercise performance with regular pea powder
Exercise performance with placebo (maltodextrin)
Time frame: Up to 8 weeks
blood ferritin levels
Time frame: Up to 8 weeks
Maximal aerobic capacity (mL/kg/min) measured on a treadmill
Time frame: Up to 8 weeks
Time (minutes) to complete 5 km running on a treadmill
Time frame: Up to 8 weeks
Blood hemoglobin concentration
Time frame: Up to 8 weeks
Lean tissue mass (kg) measured with dual energy X-ray absorptiometry
Time frame: Up to 8 weeks
Fat mass (kg) measured with dual energy X-ray absorptiometry
University of Saskatchewan
Other
Effect of Low-phytate Pea Powder With High Iron Bioavailability on Iron Status of Female Runners
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04945707
Anemia, Anemia, Hypochromic
Boston, Massachusetts, United States
View Trial DetailsNCT04206228
Anemia, Anemia, Hypochromic
Oslo, Norway
View Trial DetailsNCT04810546
Anemia, Anemia, Hypochromic
Chicago, Illinois, United States
View Trial DetailsNCT05309499
Anemia, Anemia, Hypochromic
Kazan', Tatarstan Republic, Russia
View Trial Details